News

“What goes up might take us upside down. Life ain’t a merry-go-round; it’s a roller coaster.” – Bon Jovi The song may not have been about international trade, but the lyrics are certainly fitting for today’s unpredictable global market.

At Frost Brown Todd’s inaugural FBT Connect™ Manufacturing event on April 8, experts opined on the regulatory impacts facing the manufacturing industry today. Jonathan Miller, partner-in-charge of Frost Brown Todd’s Washington, D.C. office, moderated the regulatory panel....

“Recent federal actions limiting the Council on Environmental Quality’s (CEQ) authority under the National Environmental Policy Act (NEPA) have created an uncertain regulatory landscape, with less clarity on how agencies will interpret and apply NEPA moving forward....

Recent legal and policy developments continue to shape the landscape for “Missing Middle” housing initiatives, impacting developers, municipalities, and communities alike.

On April 28, 2025, the U.S. Environmental Protection Agency (EPA) outlined upcoming Agency action to address per- and polyfluoroalkyl substances (PFAS).

United States Magistrate Judge James M. Wicks (E.D.N.Y.) recommended that Defendant Apple Inc.’s (“Apple”) motion to dismiss Plaintiff Joseph Wiesel’s (“Wiesel”) action for infringement of U.S. Patent No. 7,020,514 (the “’514 patent”) be granted for lack of standing and failure to state a claim.

On April 29, 2025, the U.S. Supreme Court decided Advocate Christ Medical Center, et al. v. Kennedy, No.

While the European Union continues to drive ambitious mandatory disclosure requirements, the U.S. regulatory approach is shifting rapidly under the new administration, creating uncertainty for companies.

Our investment funds team outline the latest developments within the investment funds market in Bermuda, covering the Bermuda Monetary Authority ("BMA") business plan 2025, BMA Consultation Paper - operational resilience and outsourcing, BMA’s Coordinated Portfolio Investment Survey Report and in

New Mountain Capital has completed a strategic investment in SmarterDx, according to a news release. SmarterDx, founded in 2020 and based in New York, develops clinical artificial intelligence focused on revenue integrity and care quality....

Pages